ÂÜÀòÂÒÂ×

Professor Otavio Berwanger is Executive Director for The George Institute for Global Health, UK and Chair in Public Health at Imperial College London. In his capacity as Executive Director he leads the Institute’s work in partnership with Imperial College London, with its core focus on health systems science, multimorbidity, women’s health, large-scale clinical trials and planetary health. He will also build on his personal research interests in exploring innovative clinical trial models, as well as the conduct of efficient implementation science studies.

Prior to joining The George Institute, UK, Otavio was Director of the Academic Research Organization (ARO) of the Albert Einstein Israelite Hospital in São Paulo, Brazil. An esteemed cardiologist and clinical trialist, Otavio has extensive research and managerial experience and has led large-scale, randomised clinical trials nationally and internationally across countries including Brazil, Australia, New Zealand, Canada, China, Chile, Argentina, Peru and Colombia. Trials led by Otavio have been published in high-impact journals such as the New England Journal of Medicine, Lancet, JAMA and BMJ.